Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease: Risk Models From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) [Original Articles]

Conclusions:
The health status outcomes of stable ischemic heart disease patients treated by OMT+PCI versus OMT alone can be predicted with modest accuracy. Angina and quality of life at 1 year is improved by PCI but is more strongly associated with other patient characteristics.

Clinical Trial Registration:
URL: https://www.clinicaltrials.gov. Unique identifier: NCT00007657.

Source: Circulation: Cardiovascular Quality and Outcomes - May 11, 2018 Category: Cardiology Authors: Zhang, Z., Jones, P., Weintraub, W. S., Mancini, G. B. J., Sedlis, S., Maron, D. J., Teo, K., Hartigan, P., Kostuk, W., Berman, D., Boden, W. E., Spertus, J. A. Tags: Quality and Outcomes Original Articles Source Type: research